U-Neuron Biomedical

U-Neuron Biomedical Dividend

Dividend of U-Neuron Biomedical (6973.TWO) as of Nov 21, 2026.

Dividend

0.00TWD

Last updated:

How much dividend does U-Neuron Biomedical 2026 pay?

According to the latest status from November 2026, U-Neuron Biomedical paid a total of 0.00 TWD per share in dividends within the last 12 months. With the current U-Neuron Biomedical price of 50.20 TWD, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Historical U-Neuron Biomedical Dividends

Historical U-Neuron Biomedical Dividends
PaydateDividend

The U-Neuron Biomedical Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2021
0.00 TWD
Jan 1, 2022
0.00 TWD
Jan 1, 2023
0.00 TWD
Jan 1, 2024
0.00 TWD
The U-Neuron Biomedical Dividend history
YEARDividendYoY
0.00TWD—
0.00TWD—
0.00TWD—
0.00TWD—

Is the U-Neuron Biomedical Dividend Safe?

U-Neuron Biomedical has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Dividend Details

Understanding U-Neuron Biomedical's Dividend Distributions

U-Neuron Biomedical’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining U-Neuron Biomedical's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

U-Neuron Biomedical's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in U-Neuron Biomedical’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

U-Neuron Biomedical Stock analysis

What does U-Neuron Biomedical do? U-Neuron Biomedical Inc develops cosmetics, health care consumer products, and new drugs using allogeneic amniotic fluid stem cells and their derivatives. The company's new drug portfolio includes UA002 for erectile dysfunction and UB003 for dry eye, while its cosmetic line features masks, essences, and creams for anti-aging, repairing, and moisturizing. These products are primarily sold within Taiwan, targeting domestic consumers seeking medical beauty and health care solutions. The company leverages the regenerative properties of amniotic fluid stem cells to create applications in both therapeutic and cosmetic segments. The business model focuses on developing products around deer amniotic fluid stem cell derivatives for cosmetics, which form the core of its health care consumer product line. UA002 and UB003 represent the company's pharmaceutical offerings, addressing specific medical conditions with stem cell-based treatments. Domestic sales drive revenue, with no mention of international markets or additional distribution channels in the provided description. U-Neuron Biomedical Inc's revenue streams come from the domestic sale of its cosmetic products and pharmaceuticals. The company's product segments are clearly divided between new drug development and cosmetic/health care consumer products, with each segment utilizing stem cell technology in different applications. Sales are concentrated within Taiwan, where the company's products meet local demand for regenerative medicine and beauty solutions. U-Neuron Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about U-Neuron Biomedical stock

U-Neuron Biomedical paid dividends every year for the past 0 years.

U-Neuron Biomedical is assigned to the 'Health' sector.

The dividends of U-Neuron Biomedical are distributed in TWD.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

All Key Metrics — U-Neuron Biomedical